On ECHEMI
Home > Drugs > Preterm birth
Preterm birth
In 1935, the American Academy of Pediatrics proposed that any live birth with a weight of 2500g or less is considered premature. In the subsequent clinical application process, people realized that there can be a large difference between gestational age and actual fetal weight when fetal growth is restricted. Therefore, in 1961, the World Health Organization established a standard for gestational age for premature birth, defining births of those who gave birth at less than 37 weeks of gestation as premature, but did not set a lower limit. There is no unified definition of premature birth at home and abroad. At present, my country defines premature birth as births of 28 to less than 37 weeks of gestation, calculated from the first day of the last menstrual period. People divide premature births into three categories based on gestational age: 1. Extreme premature births occur between 20 and 28 weeks of gestation, accounting for 5%. 2. Early premature births occur at <32 weeks of gestation, accounting for 10%. 3. Premature births between 32 and 36 weeks of gestation are considered mild premature births, accounting for 85%. Some scholars further divide 32-36 weeks into two subgroups, calling premature births before 32-34 weeks moderate premature births, and premature births between 34 and 36 weeks mild premature births.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Pregnant women between 28 and 37 weeks of pregnancy
  • Related symptoms:

    Cervical dilatation Threatened premature labor Premature rupture of membranes Vaginal bleeding Stomach ache
  • Concurrent disease:

Related Drugs
Compound Amino Acid Injection for Children (18AA-Ⅰ)
Indication: Children with digestive system diseases, hypoproteinemia caused by various diseases, severe trauma, burns, sepsis and other nitrogen imbalances in the body, refractory diarrhea, malabsorption syndrome, parenteral nutrition for premature infants and low birth weight infants.
Manufacturer:

Hubei Jinyao Pharmaceutical Co., Ltd.

Compound Amino Acid Injection for Children (18AA-Ⅰ)
Indication: Children with digestive system diseases, hypoproteinemia caused by various diseases, severe trauma, burns, sepsis and other nitrogen imbalances in the body, refractory diarrhea, malabsorption syndrome, parenteral nutrition for premature infants and low birth weight infants.
Manufacturer:

Tianjin Pharmaceutical Heping (Tianjin) Pharmaceutical Co., Ltd.

Porcine lung phospholipid injection
Indication: Treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
Porcine lung phospholipid injection
Indication: Guersu (porcine alfa injection) can reduce the mortality and major pulmonary complications of respiratory distress syndrome. It is used to prevent and treat respiratory distress syndrome (RDS) in premature infants.
Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Sancai Shiqi Pharmaceutical Co., Ltd.

Vitamin E soft capsules
Indication: 1. For newborns, premature infants, and low birth weight infants born to mothers who do not eat fortified milk powder or have severe fat malabsorption. 2. Routine use of this product in immature infants and low birth weight infants can prevent hemolytic anemia caused by vitamin E deficiency, and can reduce the formation of retrobulbar fibrous tissue (which can cause blindness) and bronchial-pulmonary system dysplasia caused by oxygen poisoning. However, some people believe that the above effects need further research and confirmation. 3. For the adjuvant treatment of progressive muscular dystrophy.
Manufacturer:

Sancai Shiqi Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.